Grants paid by The Silverstein Foundation for Parkinson's With Gba
EIN 82-0656623 · New York, NY · Form 990-PF, Part XV · NTEE T30
The Silverstein Foundation for Parkinson's With Gba of New York, NY (EIN 82-0656623) reported 13 grants paid totaling $4,262,701 to 12 recipients in tax years 2020–2024, on Form 990-PF, Part XV. It also reported $852,500 approved for future payment, which is listed separately and not included in the total. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$4,262,701
13 grants
Recipients
12
distinct organizations
Tax years
2020–2024
4 filings in the corpus
Approved for future payment
$852,500
2 commitments · not included in grants paid
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 3 | $626,701 | — |
| 2022 | 3 | $1,797,500 | $852,500 |
| 2023 | 6 | $1,763,500 | — |
| 2024 | 1 | $75,000 | — |
Top recipients
The 12 recipients receiving the most from The Silverstein Foundation for Parkinson's With Gba, by grants paid, out of 12 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| The New York STEM Cell Foundation 20-2905531 | B | New York, NY | 2 | $2,000,000 | 2023 |
| Chamishi Therapeutics Inc 35-2669722 | A | Deerfield, IL | 1 | $375,001 | 2020 |
| Tel Aviv Sourasky Medical Center | U | Tel Avivyafo | 1 | $276,000 | 2023 |
| Sunnybrook Research Institute | U | Toronto, ONTARIO | 1 | $250,000 | 2023 |
| Lysoway Therapeutics | U | Cambridge, MA | 1 | $225,000 | 2022 |
| Curasen Therapeutics | U | San Carlos, CA | 1 | $225,000 | 2023 |
| Michael J Fox Foundation Modag | U | New York, NY | 1 | $200,000 | 2022 |
| The Chancellor Masters and Scholars of the University of Oxford 98-6001062 | D | Oxford | 1 | $195,000 | 2023 |
| Aspen Neuroscience Inc 83-1312969 | A | San Diego, CA | 1 | $191,200 | 2020 |
| Hamad Bin Khalifa University | U | Arrayyan | 1 | $190,000 | 2023 |
| Baylor College of Medicine 74-1613878 | B | Huston, TX | 1 | $75,000 | 2024 |
| Vanqua Bio 30-1205175 | A | Deerfield, IL | 1 | $60,500 | 2020 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 15 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Baylor College of Medicine Huston, TX | B | $75,000 | paid | THE SILVERSTEIN FELLOWSHIP. | 202522589349100772 |
| 2023 | The New York STEM Cell Foundation New York, NY | B | $627,500 | paid | DRUG DISCOVERY FOR PARKINSON'S WITH GBA | 202433199349102098 |
| 2023 | Tel Aviv Sourasky Medical Center Tel Avivyafo | U | $276,000 | paid | THE ROLE OF THE IMMUNE SYSTEM IN GLUOCEREBROSIDASE (GBA)-PD: A CSF AND PBMC STUDY | 202433199349102098 |
| 2023 | Sunnybrook Research Institute Toronto, ONTARIO | U | $250,000 | paid | A PHASE I/II STUDY FOR BILATERAL PUTAMENAL DELIVERY OF RECOMBINANT GLUCOCEREBROSIDASE IN PATIENTS WITH PARKINSON'S DISEASE USING MR-GUIDED FOCUSED ULTRASOUND INDUCED OPENING OF THE BLOOD-BRAIN BARRIER | 202433199349102098 |
| 2023 | Curasen Therapeutics San Carlos, CA | U | $225,000 | paid | GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY | 202433199349102098 |
| 2023 | The Chancellor Masters and Scholars of the University of Oxford Oxford | D | $195,000 | paid | SUPPORT ONE MOVEMENT DISORDERS FELLOW FOR A TWO-YEAR PERIOD WHO HAS A FOCUS ON GBA-PARKINSON'S DISEASE RESEARCH AND/OR CLINICAL DEVELOPMENT | 202433199349102098 |
| 2023 | Hamad Bin Khalifa University Arrayyan | U | $190,000 | paid | THERAPEUTIC NANOBODY DEVELOPMENT FOR TARGETING ALPHA-SYNUCLEIN AGGREGATION IN PARKINSON'S DISEASE, WITH FOCUS ON PARKINSON'S DISEASE WITH GBA MUTATION | 202433199349102098 |
| 2022 | The New York STEM Cell Foundation New York, NY | B | $1,372,500 | paid | DRUG DISCOVERY FOR PARKINSON'S WITH GBA. | 202342419349100029 |
| 2022 | The New York STEM Cell Foundation New York, NY | B | $627,500 | approved, future | DRUG DISCOVERY FOR PARKINSON'S WITH GBA | 202342419349100029 |
| 2022 | Curasen Therapeutics San Mateo, CA | U | $225,000 | approved, future | GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY CLIN-015 | 202342419349100029 |
| 2022 | Lysoway Therapeutics Cambridge, MA | U | $225,000 | paid | EVALUATING THE THERAPEUTIC EFFECTS OF TRPML1 AND TMEM175 AGONISTS ON GBA-DEFICIENT PARKINSON'S DISEASE MODELS. | 202342419349100029 |
| 2022 | Michael J Fox Foundation Modag New York, NY | U | $200,000 | paid | FOLLOW-UP STUDY OF A DRUG (ANLE138B) - GOAL IS TO STOP THE PARKINSON'S PROTEIN ALPHA-SYNUCLEIN (A-SYN) FROM CLUMPING TOGETHER. | 202342419349100029 |
| 2020 | Chamishi Therapeutics Inc Deerfield, IL | A | $375,001 | paid | RESEARCH | 202142749349301014 |
| 2020 | Aspen Neuroscience Inc San Diego, CA | A | $191,200 | paid | RESEARCH | 202142749349301014 |
| 2020 | Vanqua Bio Deerfield, IL | A | $60,500 | paid | RESEARCH | 202142749349301014 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202522589349100772 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202433199349102098 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202342419349100029 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202142749349301014 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/820656623.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.